Page 31 - Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 11, 2024

Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

831 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ONVO

Organovo Holdings
US$0.550.2%-65.3%US$8.4mUS$6.10PS115.3xE-4.3%n/a

NLSP

NLS Pharmaceutics
US$0.19-12.6%-77.4%US$8.3mn/aPE-0.7xn/an/a

PULM

Pulmatrix
US$2.28-1.8%-10.3%US$8.3mn/aPB0.4xn/an/a

ABVC

ABVC BioPharma
US$0.69-4.3%-66.6%US$8.3mn/aPS326.7xn/an/a

PSTV

Plus Therapeutics
US$1.45-16.2%-42.0%US$8.3mUS$19.00PS1.4xE5.3%n/a

SNTI

Senti Biosciences
US$1.74-15.5%-78.3%US$8.0mn/aPS6.2xn/an/a

BNOX

Bionomics
US$0.605.3%-60.3%US$7.9mUS$10.05PS18.3xE-40.0%n/a

TENX

Tenax Therapeutics
US$4.0531.6%-82.9%US$7.9mUS$32.50PB0.6xE57.7%n/a

OGEN

Oragenics
US$1.4046.8%-56.1%US$7.8mn/aPS1046.5xn/an/a

MNPR

Monopar Therapeutics
US$0.44-36.3%-37.7%US$7.8mUS$2.39PB1.3xE-18.6%n/a

NCNA

NuCana
US$3.45-2.3%-80.0%US$7.8mUS$225.67PB0.6xE9.0%n/a

COEP

Coeptis Therapeutics Holdings
US$0.20-0.4%-81.8%US$7.5mUS$3.00PB1.7xE-5.9%n/a

KA

Kineta
US$0.606.4%-69.5%US$7.3mn/aPE-0.4xn/an/a

WINT

Windtree Therapeutics
US$12.3646.8%-52.1%US$7.3mUS$7.00PB0.5xE-100.1%n/a

VCNX

Vaccinex
US$4.58-12.4%-91.7%US$7.3mn/aPS58.5xn/an/a

PBM

Psyence Biomedical
US$0.53-3.7%-95.2%US$7.1mn/aPE-0.2xn/an/a

CYCN

Cyclerion Therapeutics
US$2.81-27.4%-21.1%US$7.0mn/aPB0.8xn/an/a

MYNZ

Mainz Biomed
US$0.32-12.5%-90.6%US$6.9mUS$2.00PS7.7xE-5.0%n/a

CVKD

Cadrenal Therapeutics
US$0.432.4%-43.2%US$6.9mUS$3.50PB1.7xE-6.4%n/a

BFRI

Biofrontera
US$1.3119.1%-87.3%US$6.7mUS$16.00PE-0.3xE68.8%n/a

JAGX

Jaguar Health
US$1.11-4.3%-96.8%US$6.4mUS$14.50PB0.5xE26.6%n/a

ALLR

Allarity Therapeutics
US$0.15-8.3%-99.7%US$6.3mn/aPB0.3xE-10.2%n/a

TBIO

Telesis Bio
US$3.67-33.3%-84.4%US$6.2mn/aPE-0.1xS-44.1%n/a

SILO

Silo Pharma
US$1.29-25.9%-36.8%US$5.7mn/aPS79.6xn/an/a
Page 31 of 35
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.